Renowned Scientists And Business Leaders Launch Cativa CBD, A Science Based CBD Brand

Monday, August 26, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Cativa CBD differentiates itself from other brands with patented protected cutting-edge technology

PORTSMOUTH, Va., August 26, 2019 /PRNewswire-PRWeb/ -- Cativa Health ("Cativa CBD"), a science-based cannabidiol (CBD)

brand set to revolutionize the wellness and CBD industries, is launching its first product line. Based on science and backed by nature, Cativa CBD products have been rigorously formulated to improve performance. The product launch was announced on August 22, 2019, in Atlanta, Georgia, to coincide with the Professional Golfers' Association (PGA) TOUR Championship.

Cativa CBD has teamed with scientists at Princeton University and the Zeeh Pharmaceutical Station of the University of Wisconsin School of Pharmacy to create best in class products. The company will launch with its Restore CBD Body Cream, a silky high-potency moisturizer crafted with a proprietary formula designed to penetrate your skin quickly and effectively. A second product, the Balance CBD Sublingual Tablets, is set to launch in early October. Cativa CBD's products are produced sustainably sourced hemp cultivated and processed in the United States. All of Cativa CBD's products are THC-free and have no psychoactive properties. Forbes reported that the U.S. CBD market could reach $20 billion by 2024.

"We are excited to enter into the CBD market with Cativa CBD," says Dr. Johnny Garcia, CEO and co-Founder of Cativa CBD. "The tremendous growth in the market proves that CBD has the power to change the future of wellness and health. It made sense to combine our science, technology, and relationships with research institutions worldwide to create CBD products with improved performance."

Cativa CBD's launch coincides with the PGA's TOUR Championship to support Marc Leishman, the company's first brand ambassador. Marc Leishman is a top-ranked Australian professional golfer who won the PGA's 2009 Rookie of the Year award. He is the first Australian to win the award.

"The fact that Marc is willing to stand with Cativa CBD is a testament to our science and the products created from it," says Professor Rodney Priestley, Cativa CBD's co-founder and Professor and Vice Dean of Innovation at Princeton University.

Cativa CBD has licensed technology developed at Princeton University and works with the Zeeh Pharmaceutical Station of the University of Wisconsin School of Pharmacy to set it apart from other CBD brands, allowing it to utilize technologies and formulations not found with other brands. The company's access to exclusive intellectual property is directly linked to the creation and manufacturing of its products.

"We are applying our expertise for the development of fundamental science and new technology in the processing and characterization of CBD," says Dr. Robert Prudhomme, Cativa CBD co-founder and Professor at Princeton University.

Cativa CBD's content-rich website provides an ongoing educational experience that customers can interact with daily to become more educated about CBD and cannabis.

For more information about Cativa CBD and to preorder products, please visit http://www.cativacbd.com.

ABOUT CATIVA Cativa CBD is a science-backed CBD brand committed to creating products that work. Founded in 2018, Cativa CBD is dedicated to using the latest in cutting-edge technology and zero-THC CBD isolates. Cativa CBD was founded with a simple mission: to combine the power of science and the promise of nature to deliver wellness and health. We believe in the untapped potential of CBD to heal the mind and body. And, we are committed to building a limitless future where technology and nature work together. We are passionate about science, sustainability, and promoting human health and the environment. And, we are passionate about you. Cativa is sold at high-end retailers and via http://www.CativaCBD.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease.

LEGAL DISCLOSURE Cativa CBD does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US CSA). The company sells and distributes hemp-based products. Cannabidiol is a natural constituent of hemp.

Media Contacts Allyson Markey, PR Manager allyson.workman@cativahealth.com 619-379-1087

 

SOURCE Cativa CBD



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store